$-0.02 EPS Expected for Bio-Path Holdings (BPTH), Mitek Systems (MITK) Has 1.19 Sentiment

July 27, 2017 - By Migdalia James

Analysts expect Bio-Path Holdings Inc (NASDAQ:BPTH) to report $-0.02 EPS on August, 8.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.02 EPS. After having $-0.01 EPS previously, Bio-Path Holdings Inc’s analysts see 100.00% EPS growth. About 79,773 shares traded. Bio-Path Holdings Inc (NASDAQ:BPTH) has declined 82.37% since July 27, 2016 and is downtrending. It has underperformed by 99.07% the S&P500.

Mitek Systems, Inc. develops, markets and sells mobile capture and identity verification software solutions for enterprise customers. The company has market cap of $350.42 million. The Company’s technology allows users to remotely deposit checks, open accounts, get insurance quotes, pay bills, as well as verify their identity by taking pictures of various documents with their camera-equipped smartphones and tablets instead of using the device keyboard. It has a 161.22 P/E ratio. The Company’s technology uses algorithms to correct image distortion, extract relevant data, route images to their desired location and process transactions.

Investors sentiment increased to 1.93 in Q4 2016. Its up 0.01, from 1.92 in 2016Q3. It is positive, as 5 investors sold Bio-Path Holdings Inc shares while 9 reduced holdings. 9 funds opened positions while 18 raised stakes. 19.14 million shares or 4.05% less from 19.95 million shares in 2016Q3 were reported. Rhumbline Advisers owns 0% invested in Bio-Path Holdings Inc (NASDAQ:BPTH) for 77,478 shares. Deutsche Bank Ag holds 51,437 shares or 0% of its portfolio. Natl Bank Of America Corporation De accumulated 0% or 14,373 shares. Moreover, Raymond James Ser Advsrs has 0.01% invested in Bio-Path Holdings Inc (NASDAQ:BPTH) for 773,806 shares. Hsbc Public Ltd Company holds 15,243 shares. 386,667 were reported by Commonwealth Equity Services. Proshare Advisors Limited Company owns 14,213 shares. Hightower Advsr Ltd Com stated it has 1.16 million shares or 0.02% of all its holdings. University Of Texas Investment Managment holds 3.83M shares or 14.72% of its portfolio. Moreover, Susquehanna Intll Group Llp has 0% invested in Bio-Path Holdings Inc (NASDAQ:BPTH) for 114,793 shares. Bnp Paribas Arbitrage holds 0% or 794 shares. Legal General Grp Incorporated Public Ltd Company holds 0% or 31,821 shares. Ironwood Inv Counsel Ltd Co stated it has 0.03% of its portfolio in Bio-Path Holdings Inc (NASDAQ:BPTH). Creative Planning stated it has 0% in Bio-Path Holdings Inc (NASDAQ:BPTH). The Illinois-based Northern Trust has invested 0% in Bio-Path Holdings Inc (NASDAQ:BPTH).

Among 2 analysts covering Bio-Path Holdings (NASDAQ:BPTH), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Bio-Path Holdings had 2 analyst reports since April 18, 2016 according to SRatingsIntel. The firm has “Buy” rating by Rodman & Renshaw given on Monday, April 18. The stock has “Buy” rating by H.C. Wainwright on Thursday, July 20.

Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The company has market cap of $36.42 million. The Firm utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. It currently has negative earnings. The Company’s drug delivery and antisense technology, DNAbilize, is a platform that uses P-ethoxy, a deoxyribonucleic acid backbone modification.

S Squared Technology Llc holds 2.6% of its portfolio in Mitek Systems, Inc. for 389,718 shares. G2 Investment Partners Management Llc owns 493,151 shares or 1.5% of their US portfolio. Moreover, P.A.W. Capital Corp has 1.04% invested in the company for 150,000 shares. The Minnesota-based White Pine Capital Llc has invested 0.8% in the stock. Thompson Davis & Co. Inc., a Virginia-based fund reported 69,175 shares.

Since January 1, 0001, it had 0 insider purchases, and 3 insider sales for $269,458 activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.